These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8383955)

  • 1. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
    Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog.
    Gillinov AM; Redmond JM; Winkelstein JA; Zehr KJ; Herskowitz A; Baumgartner WA; Cameron DE
    Ann Thorac Surg; 1994 Feb; 57(2):345-52. PubMed ID: 7906115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage.
    Chai PJ; Nassar R; Oakeley AE; Craig DM; Quick G; Jaggers J; Sanders SP; Ungerleider RM; Anderson PA
    Circulation; 2000 Feb; 101(5):541-6. PubMed ID: 10662752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and neutropenia occurring during cardiopulmonary bypass.
    Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass.
    Lazar HL; Bao Y; Gaudiani J; Rivers S; Marsh H
    Circulation; 1999 Sep; 100(13):1438-42. PubMed ID: 10500046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutrophil adhesion during cardiopulmonary bypass.
    Gillinov AM; Redmond JM; Zehr KJ; Wilson IC; Curtis WE; Bator JM; Burch RM; Reitz BA; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1994 Jan; 57(1):126-33. PubMed ID: 7904144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated bypass circuits reduce pulmonary injury.
    Redmond JM; Gillinov AM; Stuart RS; Zehr KJ; Winkelstein JA; Herskowitz A; Cameron DE; Baumgartner WA
    Ann Thorac Surg; 1993 Sep; 56(3):474-8; discussion 479. PubMed ID: 8104392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
    Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
    Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass.
    Zehr KJ; Poston RS; Lee PC; Uthoff K; Kumar P; Cho PW; Gillinov AM; Redmond JM; Winkelstein JA; Herskowitz A
    Ann Thorac Surg; 1995 Feb; 59(2):328-35. PubMed ID: 7847945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
    Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
    Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass.
    Li JS; Sanders SP; Perry AE; Stinnett SS; Jaggers J; Bokesch P; Reynolds L; Nassar R; Anderson PA
    Am Heart J; 2004 Jan; 147(1):173-80. PubMed ID: 14691437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble complement receptor type 1 inhibited the systemic organ injury caused by acid instillation into a lung.
    Nishizawa H; Yamada H; Miyazaki H; Ohara M; Kaneko K; Yamakawa T; Wiener-Kronish J; Kudoh I
    Anesthesiology; 1996 Nov; 85(5):1120-8. PubMed ID: 8916830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model.
    Kim WG; Lee BH; Seo JW
    Perfusion; 2001 May; 16(3):207-14. PubMed ID: 11419656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration.
    Tulunay M; Demiralp S; Tastan S; Akalin H; Ozyurda U; Corapcioglu T; Akarsu ES
    Anaesth Intensive Care; 1993 Feb; 21(1):50-5. PubMed ID: 8447607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine.
    Schmid RA; Zollinger A; Singer T; Hillinger S; Leon-Wyss JR; Schöb OM; Høgåsen K; Zünd G; Patterson GA; Weder W
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):90-7. PubMed ID: 9671902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest.
    Pearl JM; Schwartz SM; Nelson DP; Wagner CJ; Lyons JM; Bauer SM; Duffy JY
    Ann Thorac Surg; 2004 Mar; 77(3):994-1000. PubMed ID: 14992914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.